585 related articles for article (PubMed ID: 32000689)
1. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
3. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
6. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
7. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.
Gish RG; Yi DH; Kane S; Clark M; Mangahas M; Baqai S; Winters MA; Proudfoot J; Glenn JS
J Gastroenterol Hepatol; 2013 Sep; 28(9):1521-5. PubMed ID: 23574043
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
10. Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
Roulot D; Brichler S; Layese R; BenAbdesselam Z; Zoulim F; Thibault V; Scholtes C; Roche B; Castelnau C; Poynard T; Chazouillères O; Ganne N; Fontaine H; Gournay J; Guyader D; Le Gal F; Nahon P; Roudot-Thoraval F; Gordien E;
J Hepatol; 2020 Nov; 73(5):1046-1062. PubMed ID: 32634548
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
13. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.
Baskiran A; Akbulut S; Sahin TT; Koc C; Karakas S; Ince V; Yurdaydin C; Yilmaz S
Hepatol Int; 2020 Sep; 14(5):869-880. PubMed ID: 32895876
[TBL] [Abstract][Full Text] [Related]
14. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
Brancaccio G; Fasano M; Grossi A; Santantonio TA; Gaeta GB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1071-1076. PubMed ID: 30793345
[TBL] [Abstract][Full Text] [Related]
17. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study.
Buti M; Homs M; Rodriguez-Frias F; Funalleras G; Jardí R; Sauleda S; Tabernero D; Schaper M; Esteban R
J Viral Hepat; 2011 Jun; 18(6):434-42. PubMed ID: 20546496
[TBL] [Abstract][Full Text] [Related]
19. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
